The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment - Top-Institutions - MDSpire

The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment

  • By

  • Xingxing Tao

  • Yingjie Liu

  • Peishan Yu

  • Wenjiang Wu

  • Yanli Fu

  • Ping Lan

  • Shengzhu Jin

  • June 19, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunology
    • Metabolism

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunology
    • Tumor Microenvironment

Original Source(s)

The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment

  • by Xingxing Tao, Yingjie Liu, Peishan Yu, Wenjiang Wu, Yanli Fu, Ping Lan, Shengzhu Jin

  • June 19, 2026

Related Content

Antibody-drug conjugates in colorectal cancer: current landscape and future perspectives from clinical trials

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

2026 AACR Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min